These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7371367)

  • 21. Aminoglutethimide bioavailability, pharmacokinetics, and binding to blood constituents.
    Thompson TA; Vermeulen JD; Wagner WE; Le Sher AR
    J Pharm Sci; 1981 Sep; 70(9):1040-3. PubMed ID: 6101151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative high-performance liquid chromatographic assay for the determination of maprotiline and oxaprotiline in human plasma.
    Kuss HJ; Feistenauer E
    J Chromatogr; 1981 Jan; 204():349-53. PubMed ID: 7217264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absolute bioavailability of oral theophylline.
    Hendeles L; Weinberger M; Bighley L
    Am J Hosp Pharm; 1977 May; 34(5):525-7. PubMed ID: 868891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of pseudoephedrine and triprolidine from combination and single-ingredient products.
    Williams BO; Liao SH; Lai AA; Arnold JD; Perkins JG; Blum MR; Findlay JW
    Clin Pharm; 1984; 3(6):638-43. PubMed ID: 6509877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spironolactone. II. Bioavailability.
    Karim A; Zagarella J; Hutsell TC; Chao A; Baltes BJ
    Clin Pharmacol Ther; 1976 Feb; 19(2):170-6. PubMed ID: 1261154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of orally administered hydroflumethiazide in man.
    Yakatan GJ; Smith RB; Frome EL; Doluisio JT
    J Clin Pharmacol; 1977 Jan; 17(1):37-47. PubMed ID: 833338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and identification of hydroxylated maprotiline metabolites.
    Breyer-Pfaff U; Kroeker M; Winkler T; Kriemler P
    Xenobiotica; 1985 Jan; 15(1):57-66. PubMed ID: 3984384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy, side-effects, plasma and blood levels of maprotiline (Ludiomil).
    Miller PI; Beaumont G; Seldrup J; John V; Luscombe DK; Jones R
    J Int Med Res; 1977; 5 Suppl 4():101-11. PubMed ID: 590605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline.
    Fixley M; Shen DD; Azarnoff DL
    Am Rev Respir Dis; 1977 Jun; 115(6):955-62. PubMed ID: 262107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maprotiline in adult depressed patients. A study of the relation between clinical efficacy and serum concentrations after repeated intravenous and peroral administration.
    Fischbach R
    Arzneimittelforschung; 1979; 29(2):352-5. PubMed ID: 36112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability from various galenic formulations of flunitrazepam.
    Cano JP; Soliva M; Hartmann D; Ziegler WH; Amrein R
    Arzneimittelforschung; 1977; 27(12):2383-8. PubMed ID: 23801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetylation of maprotiline and desmethylmaprotiline in depressive patients phenotyped with sulfamidine, debrisoquine, and mephenytoin.
    Baumann P; Bosshart P; Gabris G; Gastpar M; Koeb L; Woggon B
    Arzneimittelforschung; 1988 Feb; 38(2):292-6. PubMed ID: 3370079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of bioequivalence between different formulations of isosorbide dinitrate and hydralazine and the fixed-dose combination of isosorbide dinitrate/hydralazine: the V-HeFT paradox.
    Tam SW; Sabolinski ML; Worcel M; Packer M; Cohn JN
    Clin Pharmacokinet; 2007; 46(10):885-95. PubMed ID: 17854237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gas chromatographic analysis of therapeutic concentrations of maprotiline in serum, using flame-ionization detection.
    Kärkkäinen S; Seppälä E
    J Chromatogr; 1980 Dec; 221(2):319-26. PubMed ID: 7217301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatal maprotiline intoxication.
    Curtis RA; Giacona N; Burrows D; Bauman JL; Schaffer M
    Drug Intell Clin Pharm; 1984 Sep; 18(9):716-20. PubMed ID: 6479020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.